Jennifer H. Wu

I'll research this attorney's background and verify details before writing the summary.

Let me verify the specific tracked cases and her prior firm history.

Let me verify a few more notable results and PTAB/ITC experience.

Jennifer H. Wu is a patent trial and appellate litigator whose practice centers on pharmaceuticals and biotechnology — particularly BPCIA/biologics and Hatch-Waxman matters — with additional experience in geospatial mapping, GPS devices, and medical devices. Her science background (A.B. in Biochemical Sciences, Harvard) supports the life-sciences emphasis, and directory profiles single out her work in "cutting-edge biologics cases." Her tracked patent docket itself is narrower, however: all four appearances arise from the aerial-imaging/geospatial-mapping dispute between EagleView and her client Nearmap.

Side preference. In the tracked data she appears exclusively for defendants (0 plaintiff / 4 defendant), all on the EagleView–Nearmap matters, in roles ranging from partner and of counsel to lead counsel and lead trial counsel. Her broader practice is not strictly defense-side — firm-supplied and directory bios list her as co-lead counsel for plaintiffs 10x Genomics and Stanford University in single-cell sequencing litigation and as part of the Amgen team in BPCIA litigation — so she is best described as a defense-leaning litigator who works both sides rather than a dedicated NPE/PAE prosecutor or a defense-only counsel.

Firm context. Wu is a founding partner of Groombridge, Wu, Baughman & Stone LLP, the patent-litigation boutique she launched in November 2022 with Nicholas Groombridge, J. Steven Baughman, and Eric Alan Stone, with offices in New York and Washington, D.C. All four came from Paul, Weiss, Rifkind, Wharton & Garrison, where Wu was a partner (roughly 2015–2022); before that she was an associate at Weil, Gotshal & Manges and clerked for Judge Alan D. Lourie of the U.S. Court of Appeals for the Federal Circuit.

Notable cases, PTAB/IPR, and credentials. The most prominent tracked matter is the 13-patent District of Utah geospatial-mapping litigation, Eagle View Technologies, Inc. v. Nearmap US, Inc., where she served as lead trial counsel for defendant Nearmap; related PTAB proceedings include Nearmap's IPR challenges to EagleView patents, one of which (Nearmap US, Inc. v. Eagle View Technologies, Inc., IPR2022-00734) drew Director Review that vacated and remanded a final written decision, and Eagle View Technologies, Inc. v. Nearmap US, Inc., No. 24-1488 (Fed. Cir. Feb. 3, 2026), which affirmed PTAB obviousness holdings cancelling claims of two EagleView patents (note: Federal Circuit appellate counsel for Nearmap was Fish & Richardson, not Wu's firm). At Paul Weiss she was part of the Amgen team that won a $70 million Delaware jury award against Hospira in one of the first BPCIA cases to reach trial, affirmed on appeal. She appears regularly in PTAB/IPR work through a firm Chambers ranks Band 1 nationally for PTAB practice. She is admitted in New York and New Jersey, before the U.S. Supreme Court, the Federal Circuit, the Second Circuit, the EDNY, SDNY, and the USPTO, and holds a J.D. from NYU School of Law.

Note: side-preference, firm, and technology descriptions draw on the authoritative case list plus firm/Chambers/Benchmark/Reuters profiles; the plaintiff-side matters mentioned are reported by those profiles and could not be independently confirmed in the tracked docket.